SEARCH RESULTS for assignee:"amgen"

Showing 1 to 20 of 64 results

Share this

Reel/Frame

Last Update:

Patent(s)

(X0) 14773756: POTENT AND SELECTIVE INHIBITORS OF NAV1.7

(A1) 20160024159: POTENT AND SELECTIVE INHIBITORS OF NAV1.7

(B2) 1: POTENT AND SELECTIVE INHIBITORS OF NAV1.7

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15802390: STABLE LIQUID FORMULATION OF AMG 416 (ETELCALCETIDE)

(A1) 20180080452: STABLE LIQUID FORMULATION OF AMG 416 (ETELCALCETIDE)

(B2) 1: STABLE LIQUID FORMULATION OF AMG 416 (ETELCALCETIDE)

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 14773756: POTENT AND SELECTIVE INHIBITORS OF NAV1.7

(A1) 20160024159: POTENT AND SELECTIVE INHIBITORS OF NAV1.7

(B2) 1: POTENT AND SELECTIVE INHIBITORS OF NAV1.7

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15625891: Growth Differentiation Factor 15 (GDF-15) Polypeptides

(A1) 20170291929: Growth Differentiation Factor 15 (GDF-15) Polypeptides

(B2) 1: Growth Differentiation Factor 15 (GDF-15) Polypeptides

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15367955: ANTIBODIES DIRECTED TO ANGIOPOIETIN-1 AND ANGIOPOIETIN-2 AND USES THEREOF

(A1) 20170081398: ANTIBODIES DIRECTED TO ANGIOPOIETIN-1 AND ANGIOPOIETIN-2 AND USES THEREOF

(B2) 1: ANTIBODIES DIRECTED TO ANGIOPOIETIN-1 AND ANGIOPOIETIN-2 AND USES THEREOF

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15534635: ANTI-SCLEROSTIN ANTIBODIES AND THEIR USE TO TREAT BONE DISORDERS AS PART OF A REGIMEN

(A1) 20180111986: ANTI-SCLEROSTIN ANTIBODIES AND THEIR USE TO TREAT BONE DISORDERS AS PART OF A REGIMEN

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15460961: ANTIBODY FORMULATIONS

(A1) 20170210792: ANTIBODY FORMULATIONS

(B2) 9: ANTIBODY FORMULATIONS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15300690: BIOMARKERS AND USE OF MET INHIBITOR FOR TREATMENT OF CANCER

(A1) 20170182016: BIOMARKERS AND USE OF MET INHIBITOR FOR TREATMENT OF CANCER

(B2) 1: BIOMARKERS AND USE OF MET INHIBITOR FOR TREATMENT OF CANCER

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15228717: ANTI-ERYTHROPOIETIN ANTIBODIES

(A1) 20170015743: ANTI-ERYTHROPOIETIN ANTIBODIES

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 16090562: CHIMERIC RECEPTORS TO FLT3 AND METHODS OF USE THEREOF

(A1) 20190183931: CHIMERIC RECEPTORS TO FLT3 AND METHODS OF USE THEREOF

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 29636560: AUTOINJECTOR WITH REMOVABLE CAP

(B1) D: AUTOINJECTOR WITH REMOVABLE CAP

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 29636560: AUTOINJECTOR WITH REMOVABLE CAP

(B1) D: AUTOINJECTOR WITH REMOVABLE CAP

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15714726: Variant Activin Receptor

(A1) 20180072791: Variant Activin Receptor

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15040335: METHOD OF ASSEMBLING AND FILLING A DRUG DELIVERY DEVICE

(A1) 20160199582: METHOD OF ASSEMBLING AND FILLING A DRUG DELIVERY DEVICE

(B2) 1: METHOD OF ASSEMBLING AND FILLING A DRUG DELIVERY DEVICE

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 14704794: BTNL9 Proteins, Nucleic Acids, and Antibodies and Uses Thereof

(A1) 20150344554: BTNL9 Proteins, Nucleic Acids, and Antibodies and Uses Thereof

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 16306810: DRUG DELIVERY DEVICE HAVING MINIMIZED RISK OF COMPONENT FRACTURE UPON IMPACT EVENTS

(A1) 20190167908: DRUG DELIVERY DEVICE HAVING MINIMIZED RISK OF COMPONENT FRACTURE UPON IMPACT EVENTS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15762939: SINGLE-USE AUTO-INJECTOR

(A1) 20180304014: SINGLE-USE AUTO-INJECTOR

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15004375: Stabilized Receptor Polypeptides and Uses Thereof

(A1) 20170183391: Stabilized Receptor Polypeptides and Uses Thereof

(B2) 1: Stabilized Receptor Polypeptides and Uses Thereof

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15958261: PHARMACEUTICAL FORMULATIONS AND METHODS OF MAKING THE SAME

(A1) 20180256718: PHARMACEUTICAL FORMULATIONS AND METHODS OF MAKING THE SAME

(B2) 1: PHARMACEUTICAL FORMULATIONS AND METHODS OF MAKING THE SAME

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15422619: BCMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

(A1) 20170218077: BCMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

(B2) 1: BCMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS